LX-107

N/A

Report date: 2026/03/11 20:02:12

Base Information

Drug NameLX-107
Drug Alias NameLX-107
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionAryl Hydrocarbon Receptor Interacting Protein Like 1 modulators
TargetsAryl Hydrocarbon Receptor Interacting Protein Like 1
Therapy Area/IndicationsRetinal DystrophiesRetinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesInnostellar Biotherapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInnostellar Biotherapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsRetinal DystrophiesRetinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A